EUVIMEDEUVIMED entdecken
Crossref

Targeted Degradation of EGFR Mutations via Self-Delivery Nano-PROTACs for Boosting Tumor Synergistic Immunotherapy

Xuechun Wang, Jie Yan, Yilei Zhao, Songyan Li, Zilin Ma, Xiuying Duan, Yuelan Wang, Jianwei Jiao, Changping Gu, Guiqiang Zhang iD

ACS Applied Materials & Interfaces · 09.04.2025 · 17 (14) · 20943-20956

DOI: 10.1021/acsami.5c01103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 27.03.2025. Verfasst von Xuechun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Hospital, Medical Science and Technology Innovation Center, School of Clinical and Basic Medical Sciences, Shandong First Medical…. Hauptthemen laut MEDLINE: Nanoparticles, Immunotherapy, Photosensitizing Agents, Gefitinib. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Shandong Province Traditional Chinese Medicine Science and Technology Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesImmunotherapyPhotosensitizing AgentsGefitinibLung NeoplasmsAntineoplastic AgentsAnimalsErbB ReceptorsMiceHumansPhotochemotherapyMutationProteolysisCell Line, TumorMice, Inbred BALB CFemale

Stichwörter der Autor:innen

EGFR mutationsPROTACimmunotherapyphotodynamic therapyprogrammed cell death protein ligand 1

Substanzen

ErbB ReceptorsPhotosensitizing AgentsGefitinibAntineoplastic AgentsEGFR protein, human

Autor:innen und Institutionen

  • Shandong Provincial Hospital, Medical Science and Technology Innovation Center, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 25…
  • State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.

ORCID-Profile: Guiqiang Zhang

Förderung

  • Natural Science Foundation of Shandong Province
  • Shandong Province Traditional Chinese Medicine Science and Technology Development Plan

Zitieren

APA

Wang, X., Yan, J., Zhao, Y., Li, S., Ma, Z., Duan, X., Wang, Y., Jiao, J., Gu, C., & Zhang, G. (2025). Targeted Degradation of EGFR Mutations via Self-Delivery Nano-PROTACs for Boosting Tumor Synergistic Immunotherapy. ACS Applied Materials & Interfaces, 17(14), 20943-20956. https://doi.org/10.1021/acsami.5c01103

Vancouver

Wang X, Yan J, Zhao Y, Li S, Ma Z, Duan X, et al. Targeted Degradation of EGFR Mutations via Self-Delivery Nano-PROTACs for Boosting Tumor Synergistic Immunotherapy. ACS Applied Materials & Interfaces. 2025;17(14):20943-20956. doi:10.1021/acsami.5c01103

BibTeX
@article{Wang2025,
  author = {Wang, Xuechun and Yan, Jie and Zhao, Yilei and Li, Songyan and Ma, Zilin and Duan, Xiuying and Wang, Yuelan and Jiao, Jianwei and Gu, Changping and Zhang, Guiqiang},
  title = {Targeted Degradation of EGFR Mutations via Self-Delivery Nano-PROTACs for Boosting Tumor Synergistic Immunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {20943--20956},
  doi = {10.1021/acsami.5c01103}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche